Thyrotropin-releasing hormone as a treatment for cancer-related fatigue: a randomized controlled study (Q48281648)

10 February 2018

title

Thyrotropin-releasing hormone as a treatment for cancer-related fatigue: a randomized controlled study (English)

1 reference

10 February 2018

author name string

Jayesh Kamath

series ordinal

1

1 reference

10 February 2018

Richard Feinn

series ordinal

2

1 reference

10 February 2018

Andrew Winokur

series ordinal

3

1 reference

10 February 2018

publication date

27 September 2011

1 reference

10 February 2018

Supportive Care in Cancer

published in

1 reference

10 February 2018

volume

20

1 reference

10 February 2018

issue

8

1 reference

10 February 2018

page(s)

1745-1753

1 reference

10 February 2018

https://api.crossref.org/works/10.1007%2FS00520-011-1268-8

1 reference

Fatigue in long-term breast carcinoma survivors: a longitudinal investigation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-011-1268-8

Differential effects of paroxetine on fatigue and depression: a randomized, double-blind trial from the University of Rochester Cancer Center Community Clinical Oncology Program

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-011-1268-8

I’m so tired: biological and genetic mechanisms of cancer-related fatigue

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-011-1268-8

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-011-1268-8

The thyrotropin-releasing hormone (TRH) hypothesis of homeostatic regulation: implications for TRH-based therapeutics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-011-1268-8

Thyrotropin-releasing hormone (TRH) in the neuroaxis: therapeutic effects reflect physiological functions and molecular actions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-011-1268-8

The thyrotropin-releasing hormone (TRH)-immune system homeostatic hypothesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-011-1268-8

Thyrotropin-releasing hormone can relieve cancer-related fatigue: hypothesis and preliminary observations

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-011-1268-8

Comparison of proposed diagnostic criteria with FACT-F and VAS for cancer-related fatigue: proposal for use as a screening tool

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-011-1268-8

The hospital anxiety and depression scale

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-011-1268-8

The Leeds Sleep Evaluation Questionnaire in psychopharmacological investigations - a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-011-1268-8

The Functional Assessment of Chronic Illness Therapy (FACIT) Measurement System: properties, applications, and interpretation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-011-1268-8

Increased serum prolactin after administration of synthetic thyrotropin releasing hormone (TRH) in man

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-011-1268-8

Acute effects of high-dose thyrotropin releasing hormone infusions in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-011-1268-8

TRH attenuates scopolamine-induced memory impairment in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-011-1268-8

Metabolism and excretion of exogenous thyrotropin-releasing hormone in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-011-1268-8

Thyrotropin-releasing hormone increases behavioral arousal through modulation of hypocretin/orexin neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-011-1268-8

Excitation of histaminergic tuberomamillary neurons by thyrotropin-releasing hormone

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-011-1268-8

Excitatory effects of thyrotropin-releasing hormone in the thalamus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-011-1268-8

Thyrotropin Releasing Hormone: Enhancement of Dopa Activity by a Hypothalamic Hormone

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-011-1268-8

Analysis of the anxiolytic-like effect of TRH and the response of amygdalar TRHergic neurons in anxiety.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-011-1268-8

Improvement in ratings of tension after TRH administration in healthy women.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-011-1268-8

NCCN Practice Guidelines for Cancer-Related Fatigue

21 January 2018

1 reference

12 December 2020

Fatigue and cancer: causes, prevalence and treatment approaches

1 reference

12 December 2020

Measuring fatigue and other anemia-related symptoms with the Functional Assessment of Cancer Therapy (FACT) measurement system

1 reference

12 December 2020

Rapid antidepressant response after nocturnal TRH administration in patients with bipolar type I and bipolar type II major depression

1 reference

12 December 2020

Thyrotropin-releasing hormone phase shifts circadian rhythms in hamsters

1 reference

12 December 2020

Management of fatigue in the cancer patient.

1 reference

12 December 2020

Exercise for the management of cancer-related fatigue in adults

1 reference

12 December 2020

The six-minute walk test

1 reference

12 December 2020

Drug therapy for the management of cancer-related fatigue

1 reference

12 December 2020

Response to Thyrotropin Releasing Hormone (TRH) in Normal Man

1 reference

12 December 2020

Psychosocial interventions for reducing fatigue during cancer treatment in adults

1 reference

12 December 2020

10.1007/S00520-011-1268-8

Identifiers

DOI

1 reference

10 February 2018

1 reference

10 February 2018